PSA Kinetics Is Not A Sufficient Indication For The Treatment Of Prostate Cancer.
A faculty that urologists had hoped would convert it admissible to distinguish men with prostate cancer who need treatment from those who would only need watchful waiting didn't employ well, researchers report. The technique, called PSA kinetics, measures changes in the reprove at which the prostate gland produces a protein called prostate-specific antigen try vimax. A significant augment in PSA kinetics, measured by the time during which PSA production doubles or increases at a high-speed rate, is supposed to indicate the need for treatment, by radiation therapy or surgery.
PSA kinetics has hunger been used to measure the effectiveness of treatment do you regrow eyebrow hair. A number of cancer centers have started to use it as a achievable method of distinguishing aggressive cancers that require treatment from those that are so slow-growing that they can safely be left alone.
Recent studies indicating that many men with slow-growing prostate cancers live unnecessary treatment have given seriousness to the search for such a tool, especially considering that side effects of treatment can include incontinence and impotence. But the inquiry indicates that "PSA kinetics doesn't seem to be enough to show you who you should follow and who you should treat," said Dr Ashley E Ross, a urology inhabitant at the Johns Hopkins University Brady Urological Institute, and result in author of a report on the technique published online May 3 in the Journal of Clinical Oncology.
The dispatch describes the results of PSA kinetics measurements of 290 men with low-grade prostate cancer - the charitable that often doesn't require treatment - for an average of 2,9 years. The results of PSA tests were compared with biopsies - interweaving samples - that cadenced the progression of the cancers.
The trial is part of a study, under supervision of Dr H Ballentine Carter, concert-master of the division of adult urology at the Brady Urological Institute, that began in 1994. Men in the sample had PSA tests every six months and biopsies every year.
Monday, December 22, 2014
Wednesday, December 17, 2014
Alzheimer's Disease Is Genetic Mutation
Alzheimer's Disease Is Genetic Mutation.
People with genetic mutations that leading to inherited, initially onset Alzheimer's disease overproduce a longer, stickier form of amyloid beta, the protein part that clumps into plaques in the brains of Alzheimer's patients, a small changed study has found. Researchers found that these people make about 20 percent more of a type of amyloid beta - amyloid beta 42 - than children members who do not carry the Alzheimer's mutation, according to inspect published in the June 12, 2013 edition of Science Translational Medicine different names accutane. Further, researchers Rachel Potter at Washington University School of Medicine in St Louis and colleagues found that amyloid beta 42 disappears from cerebrospinal flexible much more on the double than other known forms of amyloid beta, literary perchance because it is being deposited on plaques in the brain.
Alzheimer's researchers have long believed that brain plaques created by amyloid beta cause the retention loss and thought impairment that comes with the disease best pro med. This budding study does not prove that amyloid plaques cause Alzheimer's, but it does provide more evidence regarding the distance the disease develops and will guide future research into diagnosis and treatment, said Dr Judy Willis, a neurologist and spokesperson for the American Academy of Neurology.
The variation occurs in the presenilin gene and has beforehand been linked to increased production of amyloid beta 42 over amyloid beta 38 and 40, the other types of amyloid beta found in cerebrospinal fluid, the office said. Earlier studies of the sympathetic brain after death and using animal research have suggested that amyloid beta 42 is the most eminent contributor to Alzheimer's.
The new study confirms that connection and also quantifies overproduction of amyloid beta 42 in living charitable brains. The investigators also found that amyloid beta 42 is exchanged and recycled in the body, slowing its from from the brain. "The amyloid protein buildup has been hypothesized to correlate with the symptoms of Alzheimer's by causing neuronal damage, but we do not be informed what causes the abnormalities of amyloid overproduction and decreased removal," Willis said.
The findings from the inexperienced study "are supporting of abnormal turnover of amyloid occurring in people with the genetic mutation decades before the onset of their symptoms. Researchers conducted the learning by comparing 11 carriers of mutated presenilin genes with parentage members who do not have the mutation. They used advanced scanning technology that can "tag" and then track newly created proteins in the body.
People with genetic mutations that leading to inherited, initially onset Alzheimer's disease overproduce a longer, stickier form of amyloid beta, the protein part that clumps into plaques in the brains of Alzheimer's patients, a small changed study has found. Researchers found that these people make about 20 percent more of a type of amyloid beta - amyloid beta 42 - than children members who do not carry the Alzheimer's mutation, according to inspect published in the June 12, 2013 edition of Science Translational Medicine different names accutane. Further, researchers Rachel Potter at Washington University School of Medicine in St Louis and colleagues found that amyloid beta 42 disappears from cerebrospinal flexible much more on the double than other known forms of amyloid beta, literary perchance because it is being deposited on plaques in the brain.
Alzheimer's researchers have long believed that brain plaques created by amyloid beta cause the retention loss and thought impairment that comes with the disease best pro med. This budding study does not prove that amyloid plaques cause Alzheimer's, but it does provide more evidence regarding the distance the disease develops and will guide future research into diagnosis and treatment, said Dr Judy Willis, a neurologist and spokesperson for the American Academy of Neurology.
The variation occurs in the presenilin gene and has beforehand been linked to increased production of amyloid beta 42 over amyloid beta 38 and 40, the other types of amyloid beta found in cerebrospinal fluid, the office said. Earlier studies of the sympathetic brain after death and using animal research have suggested that amyloid beta 42 is the most eminent contributor to Alzheimer's.
The new study confirms that connection and also quantifies overproduction of amyloid beta 42 in living charitable brains. The investigators also found that amyloid beta 42 is exchanged and recycled in the body, slowing its from from the brain. "The amyloid protein buildup has been hypothesized to correlate with the symptoms of Alzheimer's by causing neuronal damage, but we do not be informed what causes the abnormalities of amyloid overproduction and decreased removal," Willis said.
The findings from the inexperienced study "are supporting of abnormal turnover of amyloid occurring in people with the genetic mutation decades before the onset of their symptoms. Researchers conducted the learning by comparing 11 carriers of mutated presenilin genes with parentage members who do not have the mutation. They used advanced scanning technology that can "tag" and then track newly created proteins in the body.
Sunday, December 7, 2014
A New Drug From Sea Sponge For The Treatment Of Severe Breast Cancer
A New Drug From Sea Sponge For The Treatment Of Severe Breast Cancer.
A original chemotherapy soporific made from a quantity sponge extended the lives of women with metastatic breast cancer by about 2,5 months, researchers report. The encouraging finding on the drug, known as eribulin, was presented Sunday at the annual intersection of the American Society of Clinical Oncology in Chicago. "We have a major need for unripe therapies," noted study author Dr Christopher Twelves helpful resources. "We see a statistically significant promote in overall survival in a situation where we rarely see this sort of improvement".
So "Eribulin targets the mechanisms by which the cells divide, which is several from previous agents," explained Twelves, who is a professor of clinical cancer pharmacology and oncology and nut of the Clinical Cancer Research Groups at the Leeds Institute of Molecular Medicine and St James' Institute of Oncology in Leeds, UK. More than 750 women were randomized to find out either eribulin or a "treatment of physician's choice," the behind because there isn't a standard therapy for this type of cancer, Leeds explained mental health to do or not to do the question of child counseling. In almost all cases, it was another chemotherapy.
The study included women who had already been treated extensively for their cancer, with the general patient already having undergone four chemotherapies. The researchers announcement a 23 percent improvement in median survival when women took eribulin, with the median survival for those in the eribulin faction at just over 13 months vs 10,7 months in the treatment-of -choice group. "These results potentially found eribulin as a new and effective healing for women with heavily pretreated breast cancer," said Twelves, who disclosed financial ties with Eisai, which makes eribulin.
Also featured at the assembly Sunday, Italian researchers report that liver biopsies can ventilate whether a breast cancer that has spread through the body has changed its cellular characteristics, such as estrogen-receptor status, progesterone-receptor reputation or HER2 status. These tumor properties often dictate the type of remedying a woman receives, meaning that some women may benefit from switching therapy if the characteristics of their cancer change.
A original chemotherapy soporific made from a quantity sponge extended the lives of women with metastatic breast cancer by about 2,5 months, researchers report. The encouraging finding on the drug, known as eribulin, was presented Sunday at the annual intersection of the American Society of Clinical Oncology in Chicago. "We have a major need for unripe therapies," noted study author Dr Christopher Twelves helpful resources. "We see a statistically significant promote in overall survival in a situation where we rarely see this sort of improvement".
So "Eribulin targets the mechanisms by which the cells divide, which is several from previous agents," explained Twelves, who is a professor of clinical cancer pharmacology and oncology and nut of the Clinical Cancer Research Groups at the Leeds Institute of Molecular Medicine and St James' Institute of Oncology in Leeds, UK. More than 750 women were randomized to find out either eribulin or a "treatment of physician's choice," the behind because there isn't a standard therapy for this type of cancer, Leeds explained mental health to do or not to do the question of child counseling. In almost all cases, it was another chemotherapy.
The study included women who had already been treated extensively for their cancer, with the general patient already having undergone four chemotherapies. The researchers announcement a 23 percent improvement in median survival when women took eribulin, with the median survival for those in the eribulin faction at just over 13 months vs 10,7 months in the treatment-of -choice group. "These results potentially found eribulin as a new and effective healing for women with heavily pretreated breast cancer," said Twelves, who disclosed financial ties with Eisai, which makes eribulin.
Also featured at the assembly Sunday, Italian researchers report that liver biopsies can ventilate whether a breast cancer that has spread through the body has changed its cellular characteristics, such as estrogen-receptor status, progesterone-receptor reputation or HER2 status. These tumor properties often dictate the type of remedying a woman receives, meaning that some women may benefit from switching therapy if the characteristics of their cancer change.
Friday, November 28, 2014
New Technologies In A Therapy Of Ovarian Cancer
New Technologies In A Therapy Of Ovarian Cancer.
A untried but overture new treatment for ovarian cancer has apparently produced complete exemption for one patient with an advanced form of the disease, researchers are reporting in April 2013. The positive results of a phase 1 clinical trial for the immunotherapy approach also showed that seven other women had no measurable malady at the end of the trial, the researchers added prilosec discounts. Their results are scheduled to be presented Saturday at the American Association for Cancer Research's annual assembly in Washington, DC.
Ovarian cancer is fairly infrequent - an estimated 1,38 percent of females born today will be diagnosed with the condition - but it's an especially pitiless form of cancer because it is usually diagnosed in an advanced stage. The redesigned treatment uses a personalized vaccine to try to teach the body's immune system how to debate off tumors chudai. Researchers took bits of tumor and blood from women with stage 3 or 4 ovarian cancer and created individualized vaccines, said meditate on lead author Lana Kandalaft, principal of clinical development and operations at the Ovarian Cancer Research Center in the University of Pennsylvania's Perelman School of Medicine.
Each patient's tumor is one of a kind like a fingerprint. We're tiring to rewire the immune system to target the tumor. Once the immune system has educated how to more effectively fight the cancer, the researchers isolate immune cells called dendritic cells, persuade them to multiply, then put them back into the body to strengthen it. The research is only in the first of three stages that are required before drugs can be sold in the United States.
The first-phase studies aren't designed to choose if the drugs in point of fact work, but are instead supposed to analyze whether they're safe. This study, funded in duty by the US National Institutes of Health, found signs of improvement in 19 out of 31 patients. All 19 developed an anti-tumor inoculated response. Of those, eight had no measurable illness and are on maintenance vaccine therapy.
A untried but overture new treatment for ovarian cancer has apparently produced complete exemption for one patient with an advanced form of the disease, researchers are reporting in April 2013. The positive results of a phase 1 clinical trial for the immunotherapy approach also showed that seven other women had no measurable malady at the end of the trial, the researchers added prilosec discounts. Their results are scheduled to be presented Saturday at the American Association for Cancer Research's annual assembly in Washington, DC.
Ovarian cancer is fairly infrequent - an estimated 1,38 percent of females born today will be diagnosed with the condition - but it's an especially pitiless form of cancer because it is usually diagnosed in an advanced stage. The redesigned treatment uses a personalized vaccine to try to teach the body's immune system how to debate off tumors chudai. Researchers took bits of tumor and blood from women with stage 3 or 4 ovarian cancer and created individualized vaccines, said meditate on lead author Lana Kandalaft, principal of clinical development and operations at the Ovarian Cancer Research Center in the University of Pennsylvania's Perelman School of Medicine.
Each patient's tumor is one of a kind like a fingerprint. We're tiring to rewire the immune system to target the tumor. Once the immune system has educated how to more effectively fight the cancer, the researchers isolate immune cells called dendritic cells, persuade them to multiply, then put them back into the body to strengthen it. The research is only in the first of three stages that are required before drugs can be sold in the United States.
The first-phase studies aren't designed to choose if the drugs in point of fact work, but are instead supposed to analyze whether they're safe. This study, funded in duty by the US National Institutes of Health, found signs of improvement in 19 out of 31 patients. All 19 developed an anti-tumor inoculated response. Of those, eight had no measurable illness and are on maintenance vaccine therapy.
Wednesday, October 22, 2014
Vitamin b12 affects fractures
Vitamin b12 affects fractures.
Older men with sick levels of vitamin B-12 are at increased jeopardy for bone fractures, a new study suggests. Researchers measured the levels of vitamin B-12 in 1000 Swedish men with an run-of-the-mill age of 75. They found that participants with stubby levels of the vitamin were more likely than those with normal levels to have suffered a fracture bestvito. Men in the league with the lowest B-12 levels were about 70 percent more likely to have suffered a fracture than others in the reflect on Dec 2013.
This increased risk was primarily due to fractures in the lumbar spine, where there was an up to 120 percent greater accidental of fractures order retin-a. "The higher risk also remains when we take other risk factors for fractures into consideration, such as age, smoking, weight, bone-mineral density, too soon fractures, material activity, the vitamin D content in the blood and calcium intake," study author Catharina Lewerin, a researcher at the Sahlgrenska Academy at the University of Gothenburg, in Sweden, said in a university intelligence release.
Older men with sick levels of vitamin B-12 are at increased jeopardy for bone fractures, a new study suggests. Researchers measured the levels of vitamin B-12 in 1000 Swedish men with an run-of-the-mill age of 75. They found that participants with stubby levels of the vitamin were more likely than those with normal levels to have suffered a fracture bestvito. Men in the league with the lowest B-12 levels were about 70 percent more likely to have suffered a fracture than others in the reflect on Dec 2013.
This increased risk was primarily due to fractures in the lumbar spine, where there was an up to 120 percent greater accidental of fractures order retin-a. "The higher risk also remains when we take other risk factors for fractures into consideration, such as age, smoking, weight, bone-mineral density, too soon fractures, material activity, the vitamin D content in the blood and calcium intake," study author Catharina Lewerin, a researcher at the Sahlgrenska Academy at the University of Gothenburg, in Sweden, said in a university intelligence release.
Saturday, October 18, 2014
High Levels Of Blood HDL Cholesterol Protects Against Heart Disease And Reduces The Risk Of Cancer
High Levels Of Blood HDL Cholesterol Protects Against Heart Disease And Reduces The Risk Of Cancer.
Higher blood levels of HDL cholesterol, the "good" manner that protects against concern disease, are also strongly associated with a tone down gamble of cancer, a new review of studies suggests. "For about a 10-point increase of HDL, there is a reduced peril of cancer by about one third over an average follow-up of 4,5 years," said Dr Richard Karas, official director of the Tufts Medical Center Molecular Cardiology Research Institute and govern author of a report in the June 22 issue of the Journal of the American College of Cardiology neuroblaster - stimulant uk. Those numbers come from an judgement of 24 randomized controlled trials, aimed at determining the impression on heart disease of lowering levels of "bad" LDL cholesterol, through the use of statin drugs.
The upon singled out trials that also recorded the incidence of cancer among the participants. The researchers sign in a 36 percent lower cancer rate for every 10 milligrams per liter (mg/dl) higher stage of HDL effects. But while the relationship between higher HDL and lower cancer chance was independent of other cancer risk factors, such as smoking, obesity and age, Karas was watchful to say the study does not prove cause and effect.
So "We can say that higher levels of HDL are associated with a moderate risk of cancer, but we can't say that one causes the other," he said. Exactly so, said Dr Jennifer Robinson, professor of epidemiology and panacea at the University of Iowa College of Public Health, who wrote an accompanying editorial. High HDL levels may sparely be a marker of the good of good traits that reduce both cardiovascular and cancer risk, she said.
Higher blood levels of HDL cholesterol, the "good" manner that protects against concern disease, are also strongly associated with a tone down gamble of cancer, a new review of studies suggests. "For about a 10-point increase of HDL, there is a reduced peril of cancer by about one third over an average follow-up of 4,5 years," said Dr Richard Karas, official director of the Tufts Medical Center Molecular Cardiology Research Institute and govern author of a report in the June 22 issue of the Journal of the American College of Cardiology neuroblaster - stimulant uk. Those numbers come from an judgement of 24 randomized controlled trials, aimed at determining the impression on heart disease of lowering levels of "bad" LDL cholesterol, through the use of statin drugs.
The upon singled out trials that also recorded the incidence of cancer among the participants. The researchers sign in a 36 percent lower cancer rate for every 10 milligrams per liter (mg/dl) higher stage of HDL effects. But while the relationship between higher HDL and lower cancer chance was independent of other cancer risk factors, such as smoking, obesity and age, Karas was watchful to say the study does not prove cause and effect.
So "We can say that higher levels of HDL are associated with a moderate risk of cancer, but we can't say that one causes the other," he said. Exactly so, said Dr Jennifer Robinson, professor of epidemiology and panacea at the University of Iowa College of Public Health, who wrote an accompanying editorial. High HDL levels may sparely be a marker of the good of good traits that reduce both cardiovascular and cancer risk, she said.
Thursday, October 16, 2014
The Degree Of Harmfulness Of Video Games For Adolescent Health
The Degree Of Harmfulness Of Video Games For Adolescent Health.
Most teens who actions video games don't slump into unhealthy behaviors, but an "addicted" minority may be more apt to to smoke, use drugs, fight or become depressed, a new Yale University workroom suggests. The findings add to the large and often conflicting body of research on the effects of gaming on children, notably its link to aggressive behavior flotrol. However, this study focused on the association of gaming with defined health behaviors, and is one of the first to examine problem gaming.
And "The study suggests that, in and of itself, gaming does not appear to be harmful to kids," said study author Rani Desai, an fellow professor of psychiatry and public health at the Yale University School of Medicine. "We found to all intents and purposes no association between gaming and negative health behaviors, particularly in boys". "However, a tight but not insignificant proportion of kids find themselves unable to control their gaming," she said sildenafil pack. "That's cause for be pertinent because that inability is associated with a lot of other problem behaviors".
The study was published Nov 15, 2010 in the online printing of Pediatrics. Using data from an anonymous survey of more than 4000 public high instil students in Connecticut, taken from a separate Yale study published in 2008, the Yale yoke analyzed the prevalence of teen gaming in general, "problematic gaming," and the health behaviors associated with both.
Problem gaming was characterized as having three vital symptoms: Trying and failing to epitomize back on play, feeling an irresistible urge to play, and experiencing tension that only play could relieve. How many hours teens in truth spent thumbing their game consoles wasn't included in the resolution of problem gaming, Desai noted. "Frequency is not a determining factor," she said. While imbroglio gamers may in fact spend more hours at play, the hallmark of problem gaming is the inability to inhibit the impulse, she said.
Most teens who actions video games don't slump into unhealthy behaviors, but an "addicted" minority may be more apt to to smoke, use drugs, fight or become depressed, a new Yale University workroom suggests. The findings add to the large and often conflicting body of research on the effects of gaming on children, notably its link to aggressive behavior flotrol. However, this study focused on the association of gaming with defined health behaviors, and is one of the first to examine problem gaming.
And "The study suggests that, in and of itself, gaming does not appear to be harmful to kids," said study author Rani Desai, an fellow professor of psychiatry and public health at the Yale University School of Medicine. "We found to all intents and purposes no association between gaming and negative health behaviors, particularly in boys". "However, a tight but not insignificant proportion of kids find themselves unable to control their gaming," she said sildenafil pack. "That's cause for be pertinent because that inability is associated with a lot of other problem behaviors".
The study was published Nov 15, 2010 in the online printing of Pediatrics. Using data from an anonymous survey of more than 4000 public high instil students in Connecticut, taken from a separate Yale study published in 2008, the Yale yoke analyzed the prevalence of teen gaming in general, "problematic gaming," and the health behaviors associated with both.
Problem gaming was characterized as having three vital symptoms: Trying and failing to epitomize back on play, feeling an irresistible urge to play, and experiencing tension that only play could relieve. How many hours teens in truth spent thumbing their game consoles wasn't included in the resolution of problem gaming, Desai noted. "Frequency is not a determining factor," she said. While imbroglio gamers may in fact spend more hours at play, the hallmark of problem gaming is the inability to inhibit the impulse, she said.
Subscribe to:
Posts (Atom)